Biographical summary
Amit Mahipal, MBBS, MPH, specializes in the treatment of gastrointestinal cancers. In particular, he specializes in the treatment of:
- bile duct cancer
- pancreatic cancer
- liver cancer
- colorectal cancer
Dr. Mahipal is also involved in the development of novel therapeutic agents for gastrointestinal cancers. He is a member of Phase 1 clinical trial program at Mayo clinic and involved in drug development for oncology patients. He is the principal investigator for several early phase clinical trials including first-in-human studies. He has spearheaded several investigator initiated trials for pancreatic, liver and bile duct cancers. He is involved in developing different markers that could potentially be utilized in developing personalized therapies in the field of oncology.
In addition to his clinical and research activities, Dr. Mahipal is active in education, providing mentorship to residents and fellows. He authors expert content and publishes in high-impact scientific journals.
Conditions treated
Procedures performed
Interests
- Gastrointestinal cancers
- Cholangiocarcinoma
- Hepatocellular carcinoma
- Pancreatic cancer
- Colon cancer
- Gastroesophageal cancer
- Early cancer therapeutics/Phase 1 clinical trials
Mayo Clinic locations
Education
- 2011
Chief FellowThomas Jefferson University
- 2011
Fellow - Hematology/OncologyThomas Jefferson University Hospital
- 2008
Residency - Categorical Internal MedicineUniversity of Connecticut Health Center
- 2005
MPH - EpidemiologyUniversity of Minnesota
- 2003
MBBSMaulana Azad Medical College, Delhi University
Activities and honors
Certifications
- 2011
Medical OncologyAmerican Board of Internal Medicine
- 2011
HematologyAmerican Board of Internal Medicine
Awards and honors
- 2007
Program Director’s Letter of Commendation for Excellence in Patient CareUniversity of Connecticut Health Center
- 2006
Program Director’s Letter of Commendation for Excellence in Patient CareUniversity of Connecticut Health Center
- 2005
Henry Blackburn AwardUniversity of Minnesota
- 2005
Program Director’s Letter of Commendation for Excellence in Patient CareUniversity of Connecticut Health Center
- 2003
James L. Craig FellowshipUniversity of Minnesota
Professional memberships
- 2020 - 2021
MemberCholangiocarcinoma foundation Fellowship Review Committee
- 2018 - present
Physician LeadWatson Clinical Trial Matching Committee
- 2018 - present
Co-ChairMayo Clinic Pancreas Tumor Board
- 2018 - present
Co-ChairHepatobiliary Disease Group; Practice/Access Group
- 2018 - present
ChairPancreatic SPORE, Mayo Clinic Cancer Center
- 2014 - 2016
MemberH. Lee Moffitt Cancer Center, Department of Tumor Biology
- 2014 - 2016
MemberH. Lee Moffitt Cancer Center, International Relations Steering Committee
- 2014 - 2016
MemberH. Lee Moffitt Cancer Center, Clinical Research Action Committee
- 2014 - 2016
MemberH. Lee Moffitt Cancer Center, Research and Academic Career Committee
- 2014 - 2016
Program Committee MemberFlorida American Society of Clinical Oncology
- 2014 - 2016
MemberFlorida American Society of Clinical Oncology
- 2013 - 2016
MemberH. Lee Moffitt Cancer Center, Chemical Biology and Molecular Medicine Committee
- 2011 - 2016
MemberH. Lee Moffitt Cancer Center, Scientific Review Committee
- 2011 - 2016
MemberH. Lee Moffitt Cancer Center, Personalized Clinical Trial Committee
- 2010 - present
MemberAmerican Association for Cancer Research
- 2008 - 2011
MemberAmerican Society of Hematology
- 2008 - present
MemberAmerican Society of Clinical Oncology
- 2005 - 2008
MemberAmerican Medical Association
- 2005 - present
MemberDelta Omega (Public Health Honor Society)
Publications
Research activities